Atherosclerotic complications after renal transplantation

Transplant International

Volumn 13, Issue SUPPL. 1, 2000, Pages

  Ritz, Eberhard ^a   Schwenger, Vedat ^a   Wiesel, Manfred ^a   Zeier, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Atherosclerosis; Hyperhomocysteinemia; Hyperlipidemia; Hypertension; Left ventricular hypertrophy; Renal transplantation; Statines

Indexed keywords

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASE; COMORBIDITY; HUMAN; KIDNEY TRANSPLANTATION; MORTALITY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; REVIEW; RISK FACTOR;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; COMORBIDITY; HUMANS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 0003301206     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb02004.x     Document Type: Article

References (44)

1. Lindholm A, Albrechtsen D, Frödin L, Tufveson G, Persson NH, Lundgren G (1995) Ischemic heart disease - major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60: 451-457
2. Report from the National Kidney Foundation Task Force on Cardiovascular Disease (1998) Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?
3. Report on management of renal failure in Europe XXII, 1991 (1992) Nephrol Dial Transplant 7 [Suppl]:26
4. United States Renal Data System (1999) The 1999 annual data report. Chapter 5: patient mortality and survival. National Institute of Health, National Institute of Diabetes Digestive and Kidney Diseases, Bethesda
5. Ojo AO, Port FK, Wolfe RA, Mauger EA, Williams L, Berling DP (1994) Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. Am J Kidney Dis 24(1):59-64
6. Bonal J, Clèries M, Vela E, Renal Registry Committee (1997) Transplantation versus haemodialysis in elderly patients. Nephrol Dial Transplant 12: 261-264
7. Cosio FG, Alamir A, Yim S, Pesavento TE, Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM (1998) Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 53(3):767-772
8. Stefanski A, Schmidt KG, Waldherr R, Ritz E (1996) Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis. Kidney Int 50(4):1321-1326
9. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E (1998) Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 53(5):1343-1347
10. Kronenberg F, Kuen E, Ritz E, Junker R, König P, Lhotta K, Neyer U, Riegler P, Schwenger V, von Eckenstein A (1999) Lp(a) plasma concentrations in mild and moderate renal failure. J Am Soc Nephrol (submitted)
11. McGregor E, Jardine AG, Murray LS, Dargie HJ, Rodger RS, Junor BJ, McMillan MA, Briggs JD (1998) Preoperative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant 13: 1499-1505
12. Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE, Guttmann RD (1995) Impact of renal transplantation on uremic cardiomyopathy. Transplantation 60(9):908-914
13. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ (1996) Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7: 158-165
14. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 98-4080, November 1997. National Institutes of Health, Bethesda
15. World Health Organisation (1999) International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 17(2):151-184
16. Jacobson HR, Striker GE (1995) Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. Am J Kidney Dis 25(1):103-106
17. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL (1995) Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet In Renal Disease Study. Ann Intern Med 123: 754-762
18. Cruikshank JM, Thorp JM, Zacharias FJ (1987) Benefits and potential harm of lowering high blood pressure. Lancet i:581-584
19. Opelz G, Wujciak T, Ritz E (1998) Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 53(1):217-222
20. Schwenger V, Ritz E (1998) Audit of antihypertensive treatment in patients with renal failure. Nephrol Dial Transplant 13: 3091-3095
21. Lipkin GW, Tucker B, Giles M, Raine AE (1993) Ambulatory blood pressure and left ventricular mass in cyclosporinand non-cyclosporin-treated renal transplant recipients. J Hypertens 11(4):439-442
22. Hernandez J, Lacalzada J, Linares J, Rodriguez A, Laynez I, Higueras L, Barragan A, Perez L, Lorenzo V, Salido E, Torres A (1997) Regression of left ventricular hypertrophy (LVH) by an angiotensin-converting-enzyme inhibitor (ACEI) after renal transplantation (RT). J Am Soc Nephrol 8: 714.
23. ASN Program and Abstracts. 30th Annual Meeting 1997
24. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228
25. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD (1998) Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281: 1690-1693
26. Luo Z, Shyu K-G, Gualberto A, Walsh K (1998) Calcineurin inhibitors and cardiac hypertrophy. Nat Med 4: 1092-1093
27. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99(18):2434-2439
28. Barenbrock M, Hausberg M, Kosch M, Kisters K, Hoeks APG, Rahn KH (1998) Effect of hyperparathyroidism on arterial distensibility in renal transplant recipients. Kidney Int 54: 210-215
29. Raine AEG Cardiovascular complications after renal transplantation. In: Morris PJ (ed) Kidney transplantation, 3rd edn. Principles and Practice. W. B. Saunders Company, Philadelphia London Toronto Montreal Sydney Tokyo
30. Isoniemi H, Nurminen M, Tikkanen MJ, von Willebrand E, Krogerus L, Ahonen J, Eklund B, Hockerstedt K, Salmela K, Hayry P (1994) Risk factors predicting chronic rejection of renal allografts. Transplantation 57(1):68-71
31. Kasiske BL, Ramos EL, Gaston RS (1995) The evaluation of renal transplant candidates. Clinical practice guidelines. J Am Soc Nephrol 6: 1-34
32. Cressman MD, Heyka RJ, Paganini EP, O'Neil J, Skibinski CI, Hoff Hf (1992) Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 86: 475-482
33. Kronenberg F, Konig P, Lhotta K, Ofner D, Sandholzer C, Margreiter R, Dosch E, Utermann G, Dieplinger H (1994) Apolipoprotein(a) phenotypeassociated decrease in lipoprotein(a) plasma concentrations after renal transplantation. Arterioscler Thromb 14(9):1399-1404
34. Wanner C, Bartens W, Galle J (1995): Clinical utility of antilipidemic therapies in chronic renal allograft failure. Kidney Int 48 [Suppl 52]:60-62
35. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, Chia D, Terasaki PI, Sabad A, Cogert GA (1995) Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333(10):621-627
36. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340(2):115-126
37. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner CJ, Eklund B, Hockerstedt K, Salmela K, Hayry P (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55(2):648-658
38. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) Hyperhomcysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-1155
39. Massy ZA, Chadefaux-Vekemans B, Chevalier A, Bader CA, Drüeke TB, Legendre C, Lacour B, Kamoun P, Kreis H (1994) Hyperhomocysteinaemia: a significant risk factor for cardiovaskular disease in renal transplant recipients. Nephrol Dial Transplant 9: 1103-1108
40. Arnadottir M, Hultberg B, Vladov V, Nilsson-Ehle P, Thysell H (1996) Hyperhomocysteinemia in cyclosporintreated renal transplant recipients. Transplantation 61: 509-512
41. Ducloux D, Ruedin C, Gibey R, Vautrin P, Bresson-Vautrin C, Rebibou JM, Chalopin JM (1998) Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients. Nephrol Dial Transplant 13: 2890-2893
42. Fodinger M, Wolfl G, Fischer G, Rasoul-Rockenschaub S, Schmid R, Horl WH, Sunder-Plassmann G (1999) Effect of MTHFR 677C> T on plasma total homocysteine levels in renal graft recipients. Kidney Int 55(3):1072-1080
43. Plissonnier D, Amichot G, Duriez M, Legagneux J, Levy BI, Michel JB (1991) Effect of converting enzyme inhibition on allograft-induced arterial wall injury and response. Hypertension 18 (4) [Suppl]:II47-54
44. Haffner SM, Letho S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234